These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 24792975)

  • 21. Understanding the motion of hard-shell capsules in dry powder inhalers.
    Benque B; Khinast JG
    Int J Pharm; 2019 Aug; 567():118481. PubMed ID: 31260784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of drug loading on formulation structure and aerosol performance in carrier based dry powder inhalers.
    Young PM; Wood O; Ooi J; Traini D
    Int J Pharm; 2011 Sep; 416(1):129-35. PubMed ID: 21708238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Relationship Between the Permeability and the Performance of Carrier-Based Dry Powder Inhalation Mixtures: New Insights and Practical Guidance.
    Shalash AO; Khalafallah NM; Molokhia AM; Elsayed MMA
    AAPS PharmSciTech; 2018 Feb; 19(2):912-922. PubMed ID: 29063377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carrier particle emission and dispersion in transient CFD-DEM simulations of a capsule-based DPI.
    Benque B; Khinast JG
    Eur J Pharm Sci; 2022 Jan; 168():106073. PubMed ID: 34774996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Technological and practical challenges of dry powder inhalers and formulations.
    Hoppentocht M; Hagedoorn P; Frijlink HW; de Boer AH
    Adv Drug Deliv Rev; 2014 Aug; 75():18-31. PubMed ID: 24735675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delivery of Dry Powders to the Lungs: Influence of Particle Attributes from a Biological and Technological Point of View.
    Zellnitz S; Roblegg E; Pinto J; Fröhlich E
    Curr Drug Deliv; 2019; 16(3):180-194. PubMed ID: 30360739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Numerical Modelling of Agglomeration and Deagglomeration in Dry Powder Inhalers: A Review.
    Yang J; Wu CY; Adams M
    Curr Pharm Des; 2015; 21(40):5915-22. PubMed ID: 26446462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristics.
    Hickey AJ; Mansour HM; Telko MJ; Xu Z; Smyth HD; Mulder T; McLean R; Langridge J; Papadopoulos D
    J Pharm Sci; 2007 May; 96(5):1282-301. PubMed ID: 17455324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discrete Modelling of Powder Dispersion in Dry Powder Inhalers - A Brief Review.
    Tong Z; Yu A; Chan HK; Yang R
    Curr Pharm Des; 2015; 21(27):3966-73. PubMed ID: 26290194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lactose characteristics and the generation of the aerosol.
    Pilcer G; Wauthoz N; Amighi K
    Adv Drug Deliv Rev; 2012 Mar; 64(3):233-56. PubMed ID: 21616107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methods for reduction of cohesive forces between carrier and drug in DPI formulation.
    Desai SS; Aher AA; Kadaskar PT
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1589-98. PubMed ID: 23050727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A critical view on lactose-based drug formulation and device studies for dry powder inhalation: which are relevant and what interactions to expect?
    de Boer AH; Chan HK; Price R
    Adv Drug Deliv Rev; 2012 Mar; 64(3):257-74. PubMed ID: 21565232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of carrier particle shape on dry powder inhaler performance.
    Kaialy W; Alhalaweh A; Velaga SP; Nokhodchi A
    Int J Pharm; 2011 Dec; 421(1):12-23. PubMed ID: 21945739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing Aerosolization Using Computational Fluid Dynamics in a Pediatric Air-Jet Dry Powder Inhaler.
    Bass K; Farkas D; Longest W
    AAPS PharmSciTech; 2019 Nov; 20(8):329. PubMed ID: 31676991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative carriers in dry powder inhaler formulations.
    Rahimpour Y; Kouhsoltani M; Hamishehkar H
    Drug Discov Today; 2014 May; 19(5):618-26. PubMed ID: 24269834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nano- and Microstructured model carrier surfaces to alter dry powder inhaler performance.
    Renner N; Steckel H; Urbanetz N; Scherließ R
    Int J Pharm; 2017 Feb; 518(1-2):20-28. PubMed ID: 28025073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dry powder inhalers: a brief overview of the drug detachment techniques.
    Mehta PP
    Ther Deliv; 2020 Mar; 11(3):139-143. PubMed ID: 31914863
    [No Abstract]   [Full Text] [Related]  

  • 38. Preparation and characterization of physically modified glass beads used as model carriers in dry powder inhalers.
    Zellnitz S; Redlinger-Pohn JD; Kappl M; Schroettner H; Urbanetz NA
    Int J Pharm; 2013 Apr; 447(1-2):132-8. PubMed ID: 23470233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three-dimensional DEM-CFD analysis of air-flow-induced detachment of API particles from carrier particles in dry powder inhalers.
    Yang J; Wu CY; Adams M
    Acta Pharm Sin B; 2014 Feb; 4(1):52-9. PubMed ID: 26579364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary drug delivery by powder aerosols.
    Yang MY; Chan JG; Chan HK
    J Control Release; 2014 Nov; 193():228-40. PubMed ID: 24818765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.